ANF Stock Recent News Abercrombie & Fitch Company (ANF) 28.90

New Post Public Reply Private Reply Replies (0) Message Board

Nov 14, 2014 at 6:39 PM

Abercrombie & Fitch Company (ANF) 28.90 $ANF

The Art of Upgrades and Timing Real Spikes in Battered Stocks
at The Street - Fri Nov 14, 12:38PM CST
How to time an upgrade to anticipate a real spike in battered stocks.
SBUX: 78.12 (+0.23), ANF: 28.90 (unch), TGT: 68.13 (+0.63), DRI: 55.90 (-0.40)

Downgrade Alert for Abercrombie & Fitch (ANF)
Comtex SmarTrend(R) - Fri Nov 14, 6:53AM CST
Abercrombie & Fitch (NYSE:ANF) was downgraded from Outperform to Neutral at Credit Suisse today. The stock closed yesterday at $28.90 on volume of 2.4 million shares, below average daily volume of 2.9 million. Potential upside of 53.1% exists for Abercrombie & Fitch, based on a current level of $28.90 and analysts' average consensus price target of $44.24. The stock should find initial resistance at its 50-day moving average (MA) of $35.43 and further resistance at its 200-day MA of $38.16.
ANF: 28.90 (unch)

Analysts View on Specialty Retail Equities - Chico's FAS, Abercrombie and Fitch, Foot Locker, PetSmart, and Tractor Supply
PR Newswire - Wed Nov 12, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Chico's FAS Inc. (NYSE: CHS), Abercrombie and Fitch Company (NYSE: ANF), Foot Locker Inc. (NYSE: FL), PetSmart Inc. (NASDAQ: PETM), and Tractor Supply Company (NASDAQ: TSCO). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, November 11, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,614.90, up 0.01% and the NASDAQ Composite closed at 4,660.56, up 0.19%. The S&P 500 finished the session 0.07% higher at 2,039.68. During the trading session, five out of ten sectors finished on a higher note. The S&P 500 Consumer Discretionary Sector Index ended the day at 540.85, up 0.39%, with the index advancing 5.63% in the last one month. Register for your complimentary reports on these five stocks at:
TSCO: 74.86 (+0.91), ANF: 28.90 (unch), FL: 55.99 (+0.32), CHS: 15.63 (+0.24), PETM: 72.84 (-0.01)

Abercrombie & Fitch (ANF): Moving Average Crossover Alert - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 6:52AM CST
Abercrombie & Fitch (ANF): Moving Average Crossover Alert
ANF: 28.90 (unch)

How You Can Add Retail to Your Portfolio Now - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 2:28AM CST
How You Can Add Retail to Your Portfolio Now - Industry Outlook
SPLS: 13.45 (+0.05), AMZN: 327.82 (+11.34), AAP: 144.81 (-1.19), VFC: 71.00 (-0.34), M: 62.05 (+0.48), BKS: 22.71 (+0.04), TIF: 102.39 (-0.92), RL: 174.24 (+1.07), ARO: 2.96 (+0.09), RAD: 5.53 (+0.14), ANF: 28.90 (unch), AEO: 13.50 (-0.08), JCP: 7.38 (+0.28), CAR: 57.52 (-0.13), JWN: 74.17 (+0.92), ODP: 6.79 (+0.07), GPS: 39.51 (+0.27), FL: 55.99 (+0.32), AAPL: 114.18 (+1.36), CHS: 15.63 (+0.24)

Still No Good News From Abercrombie & Fitch
Daniel James - at Seeking Alpha - Wed Nov 12, 12:08AM CST

ANF: 28.90 (unch)

3 Great Alternatives to Abercrombie & Fitch Stock
Andrew Marder, The Motley Fool - Motley Fool - Tue Nov 11, 3:30PM CST
It looks like Abercrombie & Fitch will continue playing its role as a failing company for the foreseeable future. The clothing retailer just announced a depressing third-quarter update, sending the stock down 16% in one day. That puts the...
NKE: 95.50 (-0.62), ANF: 28.90 (unch), VFC: 71.00 (-0.34), GPS: 39.51 (+0.27)

Recent Dip Offers Investors 25% Upside At American Eagle
L&F Capital Management - at Seeking Alpha - Tue Nov 11, 2:34PM CST

ANF: 28.90 (unch), AEO: 13.50 (-0.08), GPS: 39.51 (+0.27)

26.2% Return Seen to Date on SmarTrend Abercrombie & Fitch Call (ANF)
Comtex SmarTrend(R) - Mon Nov 10, 5:05PM CST
SmarTrend identified a Downtrend for Abercrombie & Fitch (NYSE:ANF) on September 22nd, 2014 at $38.87. In approximately 2 months, Abercrombie & Fitch has returned 26.18% as of today's recent price of $28.69.
ANF: 28.90 (unch)

Abercrombie & Fitch (ANF) Breaks Through Support at $28.65
Comtex SmarTrend(R) - Mon Nov 10, 11:31AM CST
Shares of Abercrombie & Fitch (NYSE:ANF) opened today below their pivot of $30.10 and have already reached the first level of support at $28.65. Investors may be interested in a cross of the next downside pivot targets of $27.80 and $25.50.
ANF: 28.90 (unch)

Confidence in Abercombie & Fitch continues to erode
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:42AM CST

ANF: 28.90 (unch)

Abercrombie & Fitch Posts Weak Q3 Sales, Guides Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 9:45AM CST
Shares of Abercrombie & Fitch (ANF) have plunged 16.6% since the company announced its sales results and earnings outlook for the third quarter of 2014.
LB: 77.48 (+0.43), ANF: 28.90 (unch), CTRN: 22.67 (-0.02), ARO: 2.96 (+0.09)

One Reason Abercrombie & Fitch (ANF) Stock Is Falling Today
at The Street - Mon Nov 10, 9:23AM CST
Shares of Abercrombie & Fitch (ANF) are down after the company was downgraded to 'perform' from 'outperform' at Oppenheimer.
ANF: 28.90 (unch)

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
PR Newswire - Mon Nov 10, 7:45AM CST
EarningForecast.com has issued earnings forecast research with special focus on financial performance of the following stocks: Alibaba (NYSE:BABA), Genworth Financial (NYSE:GNW), Gilead Sciences (NASDAQ:GILD), Zynga (NASDAQ:ZNGA), Abercrombie & Fitch (NYSE:ANF), and Plug Power (NASDAQ

LUG).
GILD: 102.06 (-2.14), PLUG: 3.72 (-0.34), ANF: 28.90 (unch), ZNGA: 2.77 (+0.04), GNW: 9.41 (+0.11), BABA: 115.10 (+0.26)

Abercrombie & Fitch reports business update for Q3 2014
M2 - Mon Nov 10, 4:28AM CST
Abercrombie & Fitch (NYSE: ANF), a specialty retailer of casual apparel for men, women and kids, on Friday provided a business update for Q3 2014, ended 1 November 2014, and reported that net sales decreased 12% to USD911.4m, as compared to net sales of USD1.033bn in Q3 of the prior year.
ANF: 28.90 (unch)

Why We Don't Care For American Eagle
Main Street Wins - at Seeking Alpha - Mon Nov 10, 3:39AM CST

ANF: 28.90 (unch), AEO: 13.50 (-0.08)

Pity The Hedge Fund Manager
George Acs - at Seeking Alpha - Sat Nov 08, 12:13PM CST

CY: 10.04 (+0.06), EBAY: 54.36 (-0.01), MAT: 30.99 (-0.18), ANF: 28.90 (unch), IP: 54.43 (-0.29), MOS: 45.15 (-0.25), SBGI: 28.09 (+0.74), TWTR: 41.85 (+1.81), INTC: 33.95 (+0.27)

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock?
at The Street - Sat Nov 08, 4:00AM CST
The trading panel discussed whether it would help or hurt Twitter if its CEO steps down and whether Coca-Cola has any fizz left in it.
KO: 42.73 (-0.06), YHOO: 51.75 (+1.25), MNST: 107.92 (-0.24), ANF: 28.90 (unch), SLXP: 102.32 (+5.33), FFIV: 128.88 (+2.73), AKS: 6.54 (+0.22), TWTR: 41.85 (+1.81), GDX: 19.02 (+1.08), FXF: 101.78 (+0.46)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...